Reboxetine

Category: Antidepressant



Reboxetine Overview

Reboxetine, sold under the brand name Edronax among others, is a drug of the norepinephrine reuptake inhibitor (NRI) class, marketed as an antidepressant by Pfizer for use in the treatment of major depression, although it has also been used off-label for panic disorder and attention deficit hyperactivity disorder (ADHD).[3] It is approved for use in many countries worldwide, but has not been approved for use in the United States. Although its effectiveness as an antidepressant...

Read more Reboxetine Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Reboxetine

Recent Reboxetine Forums: RSS Feed

Bipolar depression

Has anyone had any success with Roboxitine ## Hello, Ann! How are you? The FDA classifies this as an NRI class antidepressant and have never approved it for use here in the U.S. due to the fact that it's efficacy has been challenged in multiple studies and reports. Thus, I find it doubtful that many people have gotten much help from it for anything. Many have found it to be no more effective than a placebo. Has anyone tried this medication? Its typical side effects are listed as possibly including nausea, dizziness, dry mouth, excessive sweating and constipation. ## I've just had a terrible time after being prescribed Reboxetine by my physchatrist. I was taking mirtazapine but suffering from severe low moods and insomnia. I've been lucky enough to have not suffered from side...

Updated

Other drugs which contain Reboxetine or a similar ingredient: (1 result)






Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 22 January 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA